IndiaCatalog.com
India News
Search Web Directory
News Home
Microsoft develops AI to help cancer doctors find the right treatments
Posted on 20th September 2016
Seattle: There are hundreds of new cancer drugs in development and new research published minute to minute, helping doctors treat patients with personalized combinations that target the specific building blocks of their disease. The problem is there’s too much to read and too many drug combinations for doctors to choose the best option every time.

Enter a Microsoft Research machine-learning project, dubbed Hanover, that aims to ingest all the papers and help predict which drugs and which combinations are most effective, according to the company.

Researchers at Oregon Health & Science University’s Knight Cancer Institute are working with Hanover’s architect, Hoifung Poon, to use the system to find drug combinations effective in fighting acute myeloid leukemia, an often-fatal cancer where treatment hasn’t improved much in decades. They include Jeff Tyner, and the institute’s director, Brian Druker, best known for pioneering Gleevec, a blockbuster drug for a different type of leukemia now owned by Novartis, that’s helped double those patients’ five-year survival rate since the 1990s.

Cancer is caused by genetic mutations that make cells grow and multiply out of control. Better ability to find those specific mutations has enabled new types of drugs that target the disease more precisely, raising the odds of survival. There are more than 800 medicines and vaccines in clinical trials to treat cancer, according to a 2015 report by Pharmaceutical Research and Manufacturers of America. At the same time, the rising speed and falling cost for sequencing genes has boosted research, the development of therapies and means more cancer patients can gain exact data on their case.

“It’s exciting, but it also provides us with the challenge of then what to do with all the data,” Knight Institute’s Tyner said. “That is where the idea of a biologist working with information scientists and computationalists is so important. The combination of all those resources is going to help make the ultimate breakthroughs for more effective, less-toxic therapies.”

In a recent interview, Poon showed a slide of a melanoma patient with tumours pocking nearly every inch of his chest. In a second photo, the lesions completely cleared up after a targeted therapy. But a third showed most of the lesions returned a few weeks later after a different mutation enabled the cancer to roar back to life. A combination of targeted drugs could work here, Poon said, but how to find it?

“There are already hundreds of these kinds of specifically targeted drugs, so even if you think let’s pair two drugs there are tens of thousands of options,” he said. “It’s very hard to wrestle with. You might need several drugs to lock down all of the tumour’s pathways.”

Hanover, a nod to a seminal 1956 AI workshop at that city’s Dartmouth College, is part of several projects announced Tuesday by Microsoft to develop computational approaches to better cancer care and study. Other projects involve a machine-learning and computer-vision system to help radiologists understand tumour progress and an effort that could one day allow scientists to program cells to fight disease.

Machine learning, where computers use data to glean insights without being explicitly programmed by humans, is increasingly aiding cancer research by parsing data in research papers, results from clinical trials, radiology reports and electronic medical records. International Business Machines Corp.’s Watson Oncology system is helping doctors interpret clinical data and develop individualized treatments. Google’s DeepMind Technologies Ltd has a medical unit and is working with the UK government health service to study whether computers can be trained to spot degenerative eye problems early enough to prevent blindness. Start-up Deep 6 Analytics in Pasadena, California, mines unstructured data like health records to find candidates for clinical trials of new drugs. Flatiron Health, backed by a Google VC unit, compiles research and patient information from cancer centers into a database and uses that to make clinical trials more efficient.

Poon’s Hanover wants to augment the work of so called tumour board reviews, where a number of doctors gather to discuss the best treatment option for patients.

“One of the bottleneck’s right now for the tumour board is to understand all this knowledge and how can you extrapolate,” he said. “This is what people have to deal with unless we can automate that process.”

Mark Craven, a professor of Biostatistics and Medical Informatics at the University of Wisconsin-Madison, has used the previous iteration of Poon’s work for research on genes potentially related to breast cancers that are resistant to the most common types of treatments, called triple-negative breast cancer.

While these kinds of machine-learning based approaches are important to new cancer care, challenges remain, according to Anil Goud, a medical director who works on things like clinical information at Cedars-Sinai hospital in Los Angeles. One is getting the information gleaned by machine-learning software into the hands of clinicians and into their regular workflow. And while some health insurers can be convinced to cover new and varied combinations of drugs if the research supports that, overall this is new territory for the insurance industry, Goud said. Researchers will also need to find enough patients who are appropriate candidates to make sure varied and new combined therapies work. He’s still hopeful though. “In oncology, it’s almost impossible for us to think this is doable without machine learning,” Goud said. “The amount of data to be able to sift through and understand what’s significant would have taken much, much, much longer if we hadn’t had this.”

Related Companies: Microsoft India (R&D) Pvt. Ltd.   

Other Latest News
Bharti Airtel defers Q2 results till Nov 14 over ambiguity on AGR verdict
Posted on 29th October 2019

Bharti Airtel said on Tuesday it has postponed its second-quarter earnings report to mid-November, as the wireless operator sought clarity on the court ruling asking telecom firms to cough up overdue payments to the government.

Shares of the company, which was expected to release its quarterly numbers later in the day, dropped 3.3 per cent in early trade.


Rupee slips 8 paise vs US dollar in early trade amid drop in oil prices
Posted on 7th October 2019
The rupee on Monday opened eight paise lower at 70.96 against the US dollar amid drop in crude oil prices and rise in Asian equities. The domestic unit on Friday closed almost flat at 70.88 against after the Reserve Bank of India (RBI) in a widely expected move cut key interest rates by 0.25 percentage point.

On a weekly basis, the local unit slumped by 32 paise.


LIC pips private insurers in first-year premium growth during April-August
Posted on 13th September 2019
In the first five months of the current financial year, first-year premiums of life insurance companies grew by 39.84% (year-on-year) at Rs 1.05 lakh crore as compared to Rs 75,588.35 crore in April-August of 2018-19.

Life Insurance Corporation of India (LIC) continued to grow at a faster pace compared to private insurance players, shows the data from the Insurance Regulatory and Development Authority of India (Irdai).


Apollo Hospitals rules out further stake sale
Posted on 13th September 2019
Apollo Hospitals Enterprise (AHEL) has ruled out further dilution of promoters’ stake in the company. The company also said its Rs 1,337-crore stake sale of Apollo Munich Health Insurance with mortgage major HDFC will be concluded by October. Following these stake sales, the promoters’ pledged position will come down from a high of 76% to 54% by October and eventually to 20% by November or December, company sources said here.

World trusts India on Kashmir, not us: Pakistan minister Ijaz Ahmed Shah
Posted on 13th September 2019
In a major embarrassment for Pakistan and its Prime Minister Imran Khan, the country's Interior Minister Ijaz Ahmed Shah, a retired brigadier, said the international community didn't believe Pakistan's narrative on Kashmir; instead it is India whose version is trusted.

» Post a FREE Classified Advertisement
Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.
Jobs in India India Real Estate Automobiles Matrimonials Beauty & Fitness

Add a comment for Microsoft develops AI to help cancer doctors find the right treatments
Please only use this form to enter comments on the above company. All comments are reviewed before they are displayed on the web site. Not all comments may be displayed. Check back with us to see if your comments have been displayed.
If you want us to email the comments posted by users, please Subscribe by email
Name*
Comments*
Security Code*
 

Be the first person to write a business review for Microsoft develops AI to help cancer doctors find the right treatments

Most Read News

More India News

Photo Gallery

Dhanush(11 Images) Dhanush
Jawaan(10 Images) Jawaan
  India Web Directory
Business Profiles
Yellow Pages
Photo Galleries
Global Web Directory
*** FREE India Classifieds
Order Premium Listings
Submit a Site
Business Reviews
Home
About us
Link to us
Advertise
Contact us
Google Search Keywords: India Catalog, IndiaCatalog, India Web Directory
    © 1999 - 2026 IndiaCatalog.com
    All Rights Reserved
Privacy Statement